rph201
Botanicalexperimental
Clinical trial activity
8 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
7
Phase 3
1
Phase 4
0
Earliest trial started Oct 1, 2011 (NCT01417299)
Timeline
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rph201
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03547206 | Phase 3 | Jul 10, 2018 | McGill University, Regenera Pharma Ltd |
| NCT03462121 | Phase 2 | Mar 1, 2018 | Regenera Pharma Ltd, Toronto Memory Program |
| NCT02045212 | Phase 2 | Feb 1, 2014 | Regenera Pharma Ltd |
| NCT01438684 | Phase 1 | Sep 1, 2012 | Hebrew University |
| NCT01513967 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2012 | INC Research, Kendle International Inc., Regenera Pharma Ltd, Toronto Memory Program |
| NCT01455480 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2011 | Regenera Pharma Ltd, Tel Aviv University |
| NCT01429519 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2011 | Regenera Pharma Ltd, Tel Aviv University, TransCom Global Ltd |
| NCT01417299 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2011 | Hebrew University |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Regenera Pharma Ltd | For profit | 6 | 6 | 2 | 2011 |
| Hebrew University | Academic/Hospital | 2 | 2 | 2 | 2011 |
| Tel Aviv University | Academic/Hospital | 2 | 0 | 1 | 2011 |
| Toronto Memory Program | Academic/Hospital | 2 | 0 | 1 | 2012 |
| INC Research | For profit | 1 | 0 | 1 | 2012 |
| Kendle International Inc. | For profit | 1 | 0 | 1 | 2012 |
| McGill University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| TransCom Global Ltd | For profit | 1 | 0 | 1 | 2011 |
8 organizations
Page 1 / 1